Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
40.74
+0.87 (2.18%)
At close: Aug 13, 2025, 4:00 PM
40.73
-0.01 (-0.02%)
After-hours: Aug 13, 2025, 4:20 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $2.91 billion as of August 13, 2025. Its market cap has increased by 6.58% in one year.
Market Cap
2.91B
Enterprise Value
2.03B
1-Year Change
6.58%
Ranking
Category
Stock Price
$40.74
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.91B, an increase of 249.06%. That is a compound annual growth rate of 28.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.85B | 9.41% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |